Position in INCY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$244,970
-$27,415 QoQ
Shares Held
2,161
-42.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#632
of 854 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026West Family Investments, Inc. holds $2,539,425 across 7 Biotechnology names. INCY ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,695 | $841,957 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,017 | $634,140 | |
| 3 | ARGX |
Argenx SE
|
374 | $346,985 | |
| 4 | INCY |
Incyte Corp
This page
|
2,161 | $244,970 | |
| 5 | RPRX |
Royalty Pharma plc
|
4,288 | $240,428 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
767 | $230,890 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
35,500 | $55 |
All Filings in INCY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $244,970 | 2,161 | Shares | Sole | 2026-08-10 | |
| 2023-03-31 | $272,385 | 3,769 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $306,340 | 3,814 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $230,774 | 3,463 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $211,120 | 2,779 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $219,755 | 2,767 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||